Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei, China.
Cell Death Dis. 2024 Jul 16;15(7):505. doi: 10.1038/s41419-024-06804-5.
During oxidative phosphorylation, mitochondria continuously produce reactive oxygen species (ROS), and untimely ROS clearance can subject mitochondria to oxidative stress, ultimately resulting in mitochondrial damage. Mitophagy is essential for maintaining cellular mitochondrial quality control and homeostasis, with activation involving both ubiquitin-dependent and ubiquitin-independent pathways. Over the past decade, numerous studies have indicated that different forms of regulated cell death (RCD) are connected with mitophagy. These diverse forms of RCD have been shown to be regulated by mitophagy and are implicated in the pathogenesis of a variety of diseases, such as tumors, degenerative diseases, and ischemia‒reperfusion injury (IRI). Importantly, targeting mitophagy to regulate RCD has shown excellent therapeutic potential in preclinical trials, and is expected to be an effective strategy for the treatment of related diseases. Here, we present a summary of the role of mitophagy in different forms of RCD, with a focus on potential molecular mechanisms by which mitophagy regulates RCD. We also discuss the implications of mitophagy-related RCD in the context of various diseases.
在线粒体氧化磷酸化过程中,线粒体不断产生活性氧(ROS),ROS 清除不及时会导致线粒体发生氧化应激,最终导致线粒体损伤。自噬对于维持细胞线粒体的质量控制和动态平衡至关重要,其激活涉及泛素依赖性和非依赖性途径。在过去的十年中,大量研究表明,不同形式的细胞程序性死亡(RCD)与自噬有关。这些不同形式的 RCD 已被证明受自噬调节,并与多种疾病的发病机制有关,如肿瘤、退行性疾病和缺血再灌注损伤(IRI)。重要的是,靶向自噬来调节 RCD 在临床前试验中显示出了极好的治疗潜力,有望成为治疗相关疾病的有效策略。在这里,我们总结了自噬在不同形式的 RCD 中的作用,重点讨论了自噬调节 RCD 的潜在分子机制。我们还讨论了自噬相关 RCD 在各种疾病中的意义。